Publications and Digital Products

The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.

This action brief provides rural communities recommended strategies for adapting promising or proven interventions to better support crisis response and pre-arrest diversion in their communities. It is the first of three briefs developed from the SAMHSA Pre-Arrest Diversion Expert Panel. 

This comprehensive kit provides substance use disorder treatment professionals with a year-long intensive outpatient treatment model. Professionals can use this model when treating clients who are dependent on stimulant drugs, such as methamphetamine and cocaine. Access family education sessions and handouts.

This resource presents program evaluation findings of a federally funded initiative that supports systems of care for community-based mental health services for children, youth, and their families. It includes data from fiscal year 2011 that track service characteristics, use, and outcomes.